speb/financial-data huggingface dataset:
NICE cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
NICE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -192108000.00
NICE cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
NICE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 59713000.00
NICE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 101637000.00
NICE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -355000.00
NICE balance_sheet (annual, 2024-12-31) — Net PPE: 278375000.00
NICE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -34962000.00
NICE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1508728000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 337763000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 68254000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 66289000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 219232000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1965000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 20291000.00
NICE balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 20291000.00
NICE balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 78751000.00
NICE balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 78751000.00
NICE income_statement (annual, 2024-12-31) — Normalized EBITDA: 810468000.00
NICE income_statement (annual, 2024-12-31) — Normalized Income: 442928180.00
NICE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 832641000.00
NICE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 3050000.00
NICE income_statement (annual, 2024-12-31) — Operating Income: 545954000.00
NICE income_statement (annual, 2024-12-31) — Operating Revenue: 2735272000.00
NICE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 63249843.00
NICE balance_sheet (annual, 2024-12-31) — Other Current Assets: 128964000.00
NICE balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 458791000.00
NICE balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 458791000.00
NICE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2843000.00
NICE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 2843000.00
NICE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -71070000.00
NICE balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -71070000.00
NICE income_statement (annual, 2024-12-31) — Other Gand A: 276936000.00
NICE income_statement (annual, 2024-12-31) — Other Income Expense: -841000.00
NICE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 231346000.00
NICE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 451000.00
NICE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 3258000.00
NICE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 37516000.00
NICE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -375000.00
NICE balance_sheet (annual, 2024-12-31) — Other Properties: 93083000.00
NICE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1139996000.00
NICE balance_sheet (annual, 2024-12-31) — Payables: 110603000.00
NICE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 700869000.00
NICE cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 3050000.00
NICE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 105910000.00
NICE balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 105910000.00
NICE income_statement (annual, 2024-12-31) — Pretax Income: 604826000.00
NICE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 3063000.00
NICE balance_sheet (annual, 2024-12-31) — Properties: 0.00
NICE balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
NICE cash_flow (annual, 2024-12-31) — Purchase Of Business: -64816000.00
NICE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -938154000.00
NICE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -34962000.00
NICE balance_sheet (annual, 2024-12-31) — Receivables: 648191000.00
NICE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 909524000.00
NICE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 205020000.00
NICE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -192108000.00
NICE cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
NICE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -369196000.00
NICE income_statement (annual, 2024-12-31) — Research And Development: 360607000.00
NICE balance_sheet (annual, 2024-12-31) — Retained Earnings: 2702397000.00
NICE balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 2702397000.00
NICE cash_flow (annual, 2024-12-31) — Sale Of Investment: 705332000.00
NICE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 642251000.00
NICE income_statement (annual, 2024-12-31) — Selling General And Administration: 919187000.00
NICE balance_sheet (annual, 2024-12-31) — Share Issued: 74774827.00
NICE income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
NICE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 182067000.00
NICE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3589742000.00
NICE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1508728000.00
NICE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -125820.00
NICE income_statement (annual, 2024-12-31) — Tax Provision: 162238000.00
NICE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.27
NICE balance_sheet (annual, 2024-12-31) — Total Assets: 5295906000.00
NICE balance_sheet (annual, 2024-12-31) — Total Capitalization: 3589742000.00
NICE balance_sheet (annual, 2024-12-31) — Total Debt: 563603000.00
NICE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3603163000.00
NICE income_statement (annual, 2024-12-31) — Total Expenses: 2189318000.00
NICE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1692743000.00
NICE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2791133000.00
NICE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 218319000.00
NICE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 545954000.00
NICE income_statement (annual, 2024-12-31) — Total Other Finance Cost: 5114000.00
NICE income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -16938000.00
NICE income_statement (annual, 2024-12-31) — Total Unusual Items: -466000.00
NICE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -466000.00
NICE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 11524984.00
NICE balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 11524984.00
NICE balance_sheet (annual, 2024-12-31) — Treasury Stock: 1339218000.00
NICE balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 1339218000.00
NICE balance_sheet (annual, 2024-12-31) — Working Capital: 1030349000.00
NICE income_statement (quarterly, 2025-03-31) — +Operating Expense: 319943000.00
NICE income_statement (quarterly, 2025-03-31) — +Total Revenue: 700192000.00
NICE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 59414000.00
NICE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 643245000.00
NICE cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -2275000.00
NICE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 63354000.00
NICE income_statement (quarterly, 2025-03-31) — Basic EPS: 2.04
NICE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 485032000.00
NICE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -20433000.00
NICE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -16766000.00
NICE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 79450000.00
NICE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 469532000.00
NICE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1610677000.00
NICE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -251654000.00
NICE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -47995000.00
NICE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 285071000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -53291000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 49518000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 5897000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -10189000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 69574000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Payable: -53291000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3773000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 28555000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 4678000.00
NICE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 94742000.00
NICE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 4678000.00
NICE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -14578000.00
NICE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3499895000.00
NICE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -252329000.00
NICE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 232080000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 637388000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Assets: 2464106000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 12200000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Debt: 459212000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 471412000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 375330000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 375330000.00
NICE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1543544000.00
NICE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -21537000.00
NICE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -21537000.00
NICE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 43441000.00
NICE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 43441000.00
NICE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 64368000.00
NICE income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.01
NICE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — EBIT: 148169000.00
NICE income_statement (quarterly, 2025-03-31) — EBITDA: 191610000.00
NICE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1147000.00
NICE cash_flow (quarterly, 2025-03-31) — End Cash Position: 471601000.00
NICE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -251654000.00
NICE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 264638000.00
NICE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 69407000.00
NICE balance_sheet (quarterly, 2025-03-31) — Goodwill: 1854973000.00
NICE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2066405000.00
NICE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 255382000.00
NICE income_statement (quarterly, 2025-03-31) — Gross Profit: 468112000.00
NICE income_statement (quarterly, 2025-03-31) — Interest Income: 15850000.00
NICE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 15850000.00
NICE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3959107000.00
NICE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -47995000.00
NICE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 67250000.00
NICE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 67250000.00
NICE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
NICE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
NICE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -36466000.00
NICE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -252329000.00
NICE cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
NICE income_statement (quarterly, 2025-03-31) — Net Income: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 129290000.00
NICE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 129290000.00
NICE income_statement (quarterly, 2025-03-31) — Net Interest Income: 15850000.00
NICE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 8904000.00
NICE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
NICE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
NICE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 15850000.00
NICE balance_sheet (quarterly, 2025-03-31) — Net PPE: 255382000.00
NICE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3667000.00
NICE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1433490000.00
NICE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 239537000.00
NICE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 62777000.00
NICE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 62123000.00
NICE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 239537000.00
NICE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 654000.00
NICE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 191610000.00
NICE income_statement (quarterly, 2025-03-31) — Normalized Income: 129290000.00
NICE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 285071000.00
NICE income_statement (quarterly, 2025-03-31) — Operating Income: 148169000.00
NICE income_statement (quarterly, 2025-03-31) — Operating Revenue: 700192000.00
NICE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 63249843.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 210184000.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 459212000.00
NICE income_statement (quarterly, 2025-03-31) — Other Gand A: 69407000.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 211432000.00
NICE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1927000.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 206497000.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 58461000.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Properties: 255382000.00
NICE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1141145000.00
NICE balance_sheet (quarterly, 2025-03-31) — Payables: 59414000.00
NICE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 696802000.00
NICE income_statement (quarterly, 2025-03-31) — Pretax Income: 164019000.00
NICE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 675000.00
NICE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -36466000.00
NICE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -49454000.00
NICE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3667000.00
NICE balance_sheet (quarterly, 2025-03-31) — Receivables: 643245000.00
NICE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 232080000.00
NICE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 43441000.00
NICE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
NICE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -252329000.00
NICE income_statement (quarterly, 2025-03-31) — Research And Development: 89102000.00
NICE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 58358000.00
NICE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 161434000.00
NICE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 230841000.00
NICE balance_sheet (quarterly, 2025-03-31) — Share Issued: 63249843.00
NICE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 43337000.00
NICE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3499895000.00
NICE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1433490000.00
NICE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NICE income_statement (quarterly, 2025-03-31) — Tax Provision: 34729000.00
NICE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
NICE balance_sheet (quarterly, 2025-03-31) — Total Assets: 5231927000.00
NICE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3499895000.00
NICE balance_sheet (quarterly, 2025-03-31) — Total Debt: 538662000.00
NICE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3499895000.00
NICE income_statement (quarterly, 2025-03-31) — Total Expenses: 552023000.00
NICE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1732032000.00
NICE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2767821000.00
NICE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 188488000.00
NICE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 148169000.00
NICE balance_sheet (quarterly, 2025-03-31) — Working Capital: 920562000.00
NICE income_statement (quarterly, 2025-06-30) — +Operating Expense: 324519000.00
NICE income_statement (quarterly, 2025-06-30) — +Total Revenue: 726712000.00
NICE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 81624000.00
NICE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 680963000.00
NICE cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -2029000.00
NICE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 62160000.00
NICE income_statement (quarterly, 2025-06-30) — Basic EPS: 3.01
NICE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 471601000.00
NICE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -22716000.00
NICE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -18137000.00
NICE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 79395000.00
NICE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 535050000.00
NICE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1631688000.00
NICE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -30506000.00
NICE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 29013000.00
NICE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 61322000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 21884000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -158979000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 2929000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -746000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -19719000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Payable: 21884000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -137095000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -14846000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -30742000.00
NICE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -200219000.00
NICE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -30742000.00
NICE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 59829000.00
NICE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3731244000.00
NICE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -30839000.00
NICE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 241601000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 473317000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Assets: 2536060000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 12516000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Debt: 459639000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 472155000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 355944000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 355944000.00
NICE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1383040000.00
NICE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -3757000.00
NICE cash_flow (quarterly, 2025-06-30) — Deferred Tax: -3757000.00
NICE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 44612000.00
NICE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 44612000.00
NICE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 63210000.00
NICE income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.96
NICE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — EBIT: 160592000.00
NICE income_statement (quarterly, 2025-06-30) — EBITDA: 205204000.00
NICE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 5139000.00
NICE cash_flow (quarterly, 2025-06-30) — End Cash Position: 536569000.00
NICE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -30506000.00
NICE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 38606000.00
NICE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 64958000.00
NICE balance_sheet (quarterly, 2025-06-30) — Goodwill: 1866226000.00
NICE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2057839000.00
NICE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 254924000.00
NICE income_statement (quarterly, 2025-06-30) — Gross Profit: 485111000.00
NICE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4190883000.00
NICE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 29013000.00
NICE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 66879000.00
NICE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 66879000.00
NICE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
NICE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 0.00
NICE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
NICE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -30839000.00
NICE income_statement (quarterly, 2025-06-30) — Net Income: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 187404000.00
NICE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 187404000.00
NICE income_statement (quarterly, 2025-06-30) — Net Interest Income: 14820000.00
NICE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 51729000.00
NICE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
NICE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
NICE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 14820000.00
NICE balance_sheet (quarterly, 2025-06-30) — Net PPE: 254924000.00
NICE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4579000.00
NICE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1673405000.00
NICE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 243665000.00
NICE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 68219000.00
NICE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 66645000.00
NICE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 243665000.00
NICE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1574000.00
NICE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 205204000.00
NICE income_statement (quarterly, 2025-06-30) — Normalized Income: 187404000.00
NICE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 61322000.00
NICE income_statement (quarterly, 2025-06-30) — Operating Income: 160592000.00
NICE income_statement (quarterly, 2025-06-30) — Operating Revenue: 726712000.00
NICE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 61743476.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 223409000.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 459639000.00
NICE income_statement (quarterly, 2025-06-30) — Other Gand A: 64958000.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 191613000.00
NICE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1999000.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 217200000.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 60306000.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Properties: 254924000.00
NICE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1096638000.00
NICE balance_sheet (quarterly, 2025-06-30) — Payables: 81624000.00
NICE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 554941000.00
NICE income_statement (quarterly, 2025-06-30) — Pretax Income: 175412000.00
NICE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 333000.00
NICE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
NICE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -24687000.00
NICE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4579000.00
NICE balance_sheet (quarterly, 2025-06-30) — Receivables: 680963000.00
NICE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 241601000.00
NICE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 44612000.00
NICE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
NICE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -30839000.00
NICE income_statement (quarterly, 2025-06-30) — Research And Development: 89762000.00
NICE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 76416000.00
NICE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 169799000.00
NICE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 234757000.00
NICE balance_sheet (quarterly, 2025-06-30) — Share Issued: 61743476.00
NICE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 37310000.00
NICE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3731244000.00
NICE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1673405000.00
NICE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NICE income_statement (quarterly, 2025-06-30) — Tax Provision: -11992000.00
NICE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
NICE balance_sheet (quarterly, 2025-06-30) — Total Assets: 5309688000.00
NICE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3731244000.00
NICE balance_sheet (quarterly, 2025-06-30) — Total Debt: 539034000.00
NICE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3731244000.00
NICE income_statement (quarterly, 2025-06-30) — Total Expenses: 566120000.00
NICE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1578444000.00
NICE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2773628000.00
NICE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 195404000.00
NICE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 160592000.00
NICE income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -14820000.00
NICE balance_sheet (quarterly, 2025-06-30) — Working Capital: 1153020000.00
NICE income_statement (quarterly, 2025-09-30) — +Operating Expense: 328295000.00
NICE income_statement (quarterly, 2025-09-30) — +Total Revenue: 731999000.00
NICE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 92114000.00
NICE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 714915000.00
NICE cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 5838000.00
NICE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 62036000.00
NICE income_statement (quarterly, 2025-09-30) — Basic EPS: 2.33
NICE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 536569000.00
NICE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -26921000.00
NICE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -19663000.00
NICE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 86854000.00
NICE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 418052000.00
NICE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 455892000.00
NICE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -500536000.00
NICE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 195725000.00
NICE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 190500000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 11596000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -35295000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 2309000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -2643000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -30806000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Payable: 11596000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -23699000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 19681000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -26621000.00
NICE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -61779000.00
NICE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -26621000.00
NICE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -114311000.00
NICE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3860746000.00
NICE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -40551000.00
NICE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 242930000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 530024000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Assets: 1382966000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 12783000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 12783000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 345315000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 345315000.00
NICE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 980236000.00
NICE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 15997000.00
NICE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 15997000.00
NICE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 48918000.00
NICE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 48918000.00
NICE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 63161000.00
NICE income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.29
NICE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — EBIT: 160774000.00
NICE income_statement (quarterly, 2025-09-30) — EBITDA: 209692000.00
NICE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -2087000.00
NICE cash_flow (quarterly, 2025-09-30) — End Cash Position: 420171000.00
NICE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -500536000.00
NICE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 163579000.00
NICE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -4463000.00
NICE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 75968000.00
NICE balance_sheet (quarterly, 2025-09-30) — Goodwill: 2438371000.00
NICE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3062428000.00
NICE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 264984000.00
NICE income_statement (quarterly, 2025-09-30) — Gross Profit: 489069000.00
NICE income_statement (quarterly, 2025-09-30) — Interest Income: 21136000.00
NICE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 21136000.00
NICE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3860746000.00
NICE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 195725000.00
NICE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 74071000.00
NICE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74071000.00
NICE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -460000000.00
NICE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 0.00
NICE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -826583000.00
NICE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -40551000.00
NICE income_statement (quarterly, 2025-09-30) — Net Income: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 144853000.00
NICE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 144853000.00
NICE income_statement (quarterly, 2025-09-30) — Net Interest Income: 21136000.00
NICE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 1049229000.00
NICE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -460000000.00
NICE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -460000000.00
NICE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 21136000.00
NICE balance_sheet (quarterly, 2025-09-30) — Net PPE: 264984000.00
NICE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -7258000.00
NICE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 798318000.00
NICE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 222486000.00
NICE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 176132000.00
NICE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 61996000.00
NICE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 222486000.00
NICE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 114136000.00
NICE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 209692000.00
NICE income_statement (quarterly, 2025-09-30) — Normalized Income: 144853000.00
NICE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 190500000.00
NICE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -4463000.00
NICE income_statement (quarterly, 2025-09-30) — Operating Income: 160774000.00
NICE income_statement (quarterly, 2025-09-30) — Operating Revenue: 731999000.00
NICE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 61743476.00
NICE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 212159000.00
NICE income_statement (quarterly, 2025-09-30) — Other Gand A: 75968000.00
NICE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 624057000.00
NICE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 5302000.00
NICE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 218658000.00
NICE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 60337000.00
NICE balance_sheet (quarterly, 2025-09-30) — Other Properties: 264984000.00
NICE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 37840000.00
NICE balance_sheet (quarterly, 2025-09-30) — Payables: 92114000.00
NICE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 622138000.00
NICE income_statement (quarterly, 2025-09-30) — Pretax Income: 181910000.00
NICE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 15000.00
NICE cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -826583000.00
NICE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -14903000.00
NICE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -7258000.00
NICE balance_sheet (quarterly, 2025-09-30) — Receivables: 714915000.00
NICE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 242930000.00
NICE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 48918000.00
NICE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -460000000.00
NICE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -40551000.00
NICE income_statement (quarterly, 2025-09-30) — Research And Development: 90463000.00
NICE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1064132000.00
NICE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 161864000.00
NICE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 237832000.00
NICE balance_sheet (quarterly, 2025-09-30) — Share Issued: 61743476.00
NICE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 35834000.00
NICE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3860746000.00
NICE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 798318000.00
NICE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
NICE income_statement (quarterly, 2025-09-30) — Tax Provision: 37057000.00
NICE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
NICE balance_sheet (quarterly, 2025-09-30) — Total Assets: 5151522000.00
NICE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3860746000.00
NICE balance_sheet (quarterly, 2025-09-30) — Total Debt: 86854000.00
NICE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3860746000.00
NICE income_statement (quarterly, 2025-09-30) — Total Expenses: 571225000.00
NICE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1290776000.00
NICE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3768556000.00
NICE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 310540000.00
NICE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 160774000.00
NICE balance_sheet (quarterly, 2025-09-30) — Working Capital: 402730000.00
NICE income_statement (annual, 2025-12-31) — +Operating Expense: 1310387000.00
NICE income_statement (quarterly, 2025-12-31) — +Operating Expense: 337630000.00
NICE income_statement (annual, 2025-12-31) — +Total Revenue: 2945399000.00
NICE income_statement (quarterly, 2025-12-31) — +Total Revenue: 786496000.00
NICE balance_sheet (annual, 2025-12-31) — Accounts Payable: 100782000.00
NICE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 100782000.00
NICE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 737954000.00
NICE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 737954000.00
NICE balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 10490000.00
NICE balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 10490000.00
NICE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -310836000.00
NICE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -310836000.00
NICE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2381750000.00
NICE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2381750000.00
NICE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -17974000.00
NICE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -17974000.00
NICE cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 100737000.00
NICE cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 100737000.00
NICE cash_flow (annual, 2025-12-31) — Amortization Of Securities: 1468000.00
NICE cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -66000.00
NICE income_statement (annual, 2025-12-31) — Basic Average Shares: 62333000.00
NICE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 61802000.00
NICE income_statement (annual, 2025-12-31) — Basic EPS: 9.82
NICE income_statement (quarterly, 2025-12-31) — Basic EPS: 2.44
NICE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 485032000.00
NICE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 420171000.00
NICE cash_flow (annual, 2025-12-31) — Capital Expenditure: -93748000.00
NICE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -23678000.00
NICE cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -74828000.00
NICE cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -20262000.00
NICE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 88801000.00
NICE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 88801000.00
NICE balance_sheet (annual, 2025-12-31) — Capital Stock: 18961000.00
NICE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 18961000.00
NICE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 379388000.00
NICE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 379388000.00
NICE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 417398000.00
NICE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 417398000.00
NICE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -984268000.00
NICE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -165106000.00
NICE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 159960000.00
NICE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -53249000.00
NICE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 716549000.00
NICE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 179656000.00
NICE cash_flow (annual, 2025-12-31) — Change In Account Payable: -15124000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 4687000.00
NICE cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -175149000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -30393000.00
NICE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 14361000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 3226000.00
NICE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -16309000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -2731000.00
NICE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -22833000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -41882000.00
NICE cash_flow (annual, 2025-12-31) — Change In Payable: -15124000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Payable: 4687000.00
NICE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -190273000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -25706000.00
NICE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 40744000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 7354000.00
NICE cash_flow (annual, 2025-12-31) — Change In Receivables: -75792000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -23107000.00
NICE cash_flow (annual, 2025-12-31) — Change In Working Capital: -250102000.00
NICE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -82846000.00
NICE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -75792000.00
NICE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -23107000.00
NICE cash_flow (annual, 2025-12-31) — Changes In Cash: -107759000.00
NICE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -38699000.00
NICE balance_sheet (annual, 2025-12-31) — Common Stock: 18961000.00
NICE balance_sheet (quarterly, 2025-12-31) — Common Stock: 18961000.00
NICE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3876528000.00
NICE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3876528000.00
NICE cash_flow (annual, 2025-12-31) — Common Stock Payments: -488911000.00
NICE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -165192000.00
NICE income_statement (annual, 2025-12-31) — Cost Of Revenue: 989254000.00
NICE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 272643000.00
NICE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 467338000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 467338000.00
NICE balance_sheet (annual, 2025-12-31) — Current Assets: 1379132000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Assets: 1379132000.00
NICE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 13742000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 13742000.00
NICE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 13742000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 13742000.00
NICE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 303911000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 303911000.00
NICE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 303911000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 303911000.00
NICE balance_sheet (annual, 2025-12-31) — Current Liabilities: 887627000.00
NICE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 887627000.00
NICE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 10495000.00
NICE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 19792000.00
NICE cash_flow (annual, 2025-12-31) — Deferred Tax: 10495000.00
NICE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 19792000.00
NICE balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 14593000.00
NICE balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 14593000.00
NICE cash_flow (annual, 2025-12-31) — Depreciation: 98307000.00
NICE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 199044000.00
NICE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 62073000.00
NICE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 199044000.00